ÃÀ¸ß÷
ÓªÒµ×Éѯ
Öйú£º
Email: marketing@medicilon.com.cn
ÓªÒµ×ÉѯרÏߣº400-780-8018
£¨½öÏÞЧÀÍ×Éѯ£¬£¬£¬£¬£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©
´¨É³×ܲ¿µç»°: +86 (21) 5859-1500
ÍâÑó£º
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com



ÔÚ9ÔÂ12ÈÕÖÁ14ÈÕ£¬£¬£¬£¬£¬ÉϺ£ÄϽ¼±ö¹Ý¾ÙÐеĵÚÈý½ì¹ú¼ÊÉúÎïÒ½Ò©¹¤ÒµÉú³¤´ó»áÉÏ£¬£¬£¬£¬£¬È«ÇòÒ½Ò©ÐÐÒµµÄ¾«Ó¢»ã¾ÛÒ»Ì㬣¬£¬£¬£¬ÅäºÏ̽ÌÖÁËÉúÎïÒ½Ò©¹¤ÒµµÄ×îÐÂÏ£ÍûºÍδÀ´Ç÷ÊÆ¡£¡£¡£¡£´ó»áͨ¹ýÖ÷Ìⱨ¸æ¡¢Ô²×À¶Ô»°µÈÐÎʽ£¬£¬£¬£¬£¬ÉîÈëÌÖÂÛÁËÁ¢ÒìÒ©Îï·¢Ã÷¡¢¿¹Ìå¡¢ÒßÃçÓëÉúÎïÖÎÁÆÐÂÁÆ·¨µÈÈÈÃÅ»°Ìâ¡£¡£¡£¡£
×÷Ϊа쵥룬£¬£¬£¬£¬ÃÀ¸ß÷ÔÚ±¾´Î´ó»áÉÏÕ¹ÏÖÁË×îм¼ÊõÓ¦ÓÃÏ£ÍûºÍЧÀÍÄÜÁ¦¡£¡£¡£¡£

ÃÀ¸ß÷Ê×ϯ¿ÆÑ§¹ÙÅíË«Çå½ÌÊÚ³öϯÁËÖ÷ÂÛ̳¸ß¶Ë¶Ô»°£¬£¬£¬£¬£¬Î§ÈÆ¡°ÉúÎïÖÆÒ©µÄδÀ´£ºÁ¢Òì¡¢î¿ÏµºÍÈ«ÇòÏàÖú¡±Ò»Ì⣬£¬£¬£¬£¬ÓëÒ½Ò©ÐÐÒµÊ×ÄÔÅäºÏ̽ÌÖÁËÉúÎïÖÆÒ©ÐÐÒµÃæÁÙµÄÌôÕ½ºÍ»úÔµ£¬£¬£¬£¬£¬ÌØÊâÊÇÔÚÁ¢ÒìÒ©ÎïÑз¢¡¢î¿ÏµÕþ²ß˳ӦÒÔ¼°È«ÇòÏàÖú·½Ãæ¡£¡£¡£¡£

Åí½ÌÊÚÖ¸³ö£¬£¬£¬£¬£¬Ëæ×ÅÉúÎï¼¼ÊõµÄ¿ìËÙÉú³¤£¬£¬£¬£¬£¬Á¢ÒìÒ©ÎïµÄÑз¢ÒѳÉΪȫÇòÒ½Ò©ÐÐÒµµÄÖ÷ÒªÇý¶¯Á¦¡£¡£¡£¡£È»¶ø£¬£¬£¬£¬£¬ÕâÒ»Àú³ÌÐèÒªÃæÁÙÖØ´óµÄî¿ÏµÇéÐκÍÑÏ¿áµÄÇå¾²±ê×¼¡£¡£¡£¡£Åí½ÌÊÚ·ÖÏíÁËÃÀ¸ß÷ÔÚм¼ÊõÓ¦Ó÷½ÃæµÄ½á¹¹£¬£¬£¬£¬£¬ÈçÈ˹¤ÖÇÄܵȣ¬£¬£¬£¬£¬ÓÐÖúÓÚÌá¸ßÑз¢Ð§ÂÊ£¬£¬£¬£¬£¬½µµÍ±¾Ç®¡£¡£¡£¡£±ðµÄ£¬£¬£¬£¬£¬Åí½ÌÊÚ»¹Ç¿µ÷ÃÀ¸ß÷ºÜÊÇ×¢ÖØÈ«ÇòÏàÖúµÄÖ÷ÒªÐÔ£¬£¬£¬£¬£¬Í¨¹ý¿ç¹ú½çµÄ½»Á÷ÓëÏàÖú£¬£¬£¬£¬£¬¿ÉÒÔ¼ÓËÙÐÂÒ©µÄÑз¢Àú³Ì£¬£¬£¬£¬£¬Ìá¸ßÒ©ÎïµÄ¿É¼°ÐԺͿɼ縺ÐÔ¡£¡£¡£¡£
ÃÀ¸ß÷ÐÂÒ©×¢²á²¿×ܼà&ÖÆ¼Á²¿¸ß¼¶Ö÷ÈÎÍõµ¤²©Ê¿·ÖÏíÁË¡°BL-602, A Cyclophilin Inhibitor, Reduces Fibrosis and Proteinuria in Chronic Kidney Disease¡±£¬£¬£¬£¬£¬Ïêϸ½éÉÜÁËBL-602ÔÚÂýÐÔÉö²¡ÖÎÁÆÖеÄÓ¦ÓÃÔ¶¾°£¬£¬£¬£¬£¬²¢·ÖÏíÁËÔںϳɡ¢ÖƼÁ¿ª·¢¡¢Ò©´ú¶¯Á¦Ñ§¡¢Çå¾²ÐÔÆÀ¹ÀÒÔ¼°ÌåÍâºÍÌåÄÚÃâÒß»îÐԲⶨµÈ·½ÃæµÄÑо¿ÇéÐΡ£¡£¡£¡£

BL-602×÷ΪһÖÖ»·æßËØÒÖÖÆ¼Á£¬£¬£¬£¬£¬Æäҩѧ¿ª·¢ÃæÁÙ×ÅÖî¶àÌôÕ½£¬£¬£¬£¬£¬ºÃ±ÈÆðʼÎïÁϲúÂʽϵͣ¬£¬£¬£¬£¬ÔöÌíÁ˺ϳɵÄÄѶȣ»£»£»ÔÚÖÆ¼Á¿ª·¢·½Ã棬£¬£¬£¬£¬BL-602µÄÉúÎïʹÓöȽϵͣ¬£¬£¬£¬£¬ÒªÇóÑз¢ÍŶӾÙÐÐÁ¢ÒìÒÔÌá¸ßÆä¿Ú·þÎüÊÕ¡£¡£¡£¡£±ðµÄ£¬£¬£¬£¬£¬BL-602µÄÒ©´ú¶¯Á¦Ñ§ÌØÕ÷¡¢Çå¾²ÐÔÆÀ¹ÀÒÔ¼°ÃâÒß»îÐԵIJ⽨¶¼ÊÇÑз¢Àú³ÌÖеÄÒªº¦»·½Ú¡£¡£¡£¡£
Íõ²©Ê¿µÄÑݽ²²»µ«Õ¹Ê¾ÁËBL-602ÔÚÖÎÁÆÂýÐÔÉö²¡·½ÃæµÄDZÁ¦£¬£¬£¬£¬£¬Ò²·´Ó¦ÁËÃÀ¸ß÷ÔÚÒ©ÎïÖÆ¼ÁÑз¢ÁìÓòµÄרҵÄÜÁ¦ºÍÁ¢Ò쾫Éñ¡£¡£¡£¡£ËýµÄ·ÖÏíΪÓë»áÕßÌṩÁËÃû¹óµÄÐÅÏ¢£¬£¬£¬£¬£¬ÓÐÖúÓÚÍÆ¶¯Ïà¹ØÒ©ÎïÑз¢µÄÏ£Íû¡£¡£¡£¡£

ÃÀ¸ß÷ҩЧ²¿ÏîĿ˾ÀíÔ¬ÔÆÔÆ²©Ê¿ÔÚ¼²²¡Ä£×ÓÓëÓ¦Ó÷ÖÂÛ̳ÉÏ·ÖÏíÁË¡°Animal Models of Human Diseases and the Application in Pharmacodynamic Studies¡±µÄרÌⱨ¸æ£¬£¬£¬£¬£¬Ç¿µ÷Á˶¯ÎïÄ£×ÓÔÚÈËÀ༲²¡Ò©Ð§Ñо¿ÖеÄÖ÷ÒªÐÔ£¬£¬£¬£¬£¬²¢½éÉÜÁËÃÀ¸ß÷ÔÚÕâÒ»ÁìÓòµÄЧÀÍÄÜÁ¦¡£¡£¡£¡£
ÃÀ¸ß÷ҩЧ²¿ÒÀÍжàÄêµÄÁÙ´²Ç°Ò©ÀíҩЧÑо¿¼°ÐÂÒ©Ñз¢ÂÄÀú£¬£¬£¬£¬£¬Àֳɽ¨ÉèÁË270ÓàÖÖ·ÇÖ×ÁöҩЧÆÀ¼ÛÄ£×Ó¡£¡£¡£¡£ÕâЩģ×Óº¸ÇÁËÑ×Ö¢ºÍÃâÒßÐÔ¼²²¡¡¢¾«ÉñÉñ¾ÏµÍ³¼²²¡¡¢Ïû»¯ÏµÍ³¼²²¡¡¢´úлÐÔ¼²²¡ºÍÐÄѪ¹Ü¼²²¡µÈ¶à¸öÁìÓò¡£¡£¡£¡£Ô¬²©Ê¿Ïêϸ½éÉÜÁËÕâЩģ×ӵĽ¨ÉèÀú³Ì¡¢Ó¦Óó¡¾°ÒÔ¼°ÔÚҩЧÆÀ¼ÛÖеÄ×÷Óᣡ£¡£¡£
±ðµÄ£¬£¬£¬£¬£¬Ô¬²©Ê¿»¹·ÖÏíÁËÃÀ¸ß÷ÔÚ·ÇÖ×ÁöҩЧЧÀÍÍŶӵĽ¨É裬£¬£¬£¬£¬ÒÔ¼°ÔõÑùƾ֤¿Í»§ÐèÇóÌṩ¶¨ÖÆ»¯µÄҩЧÑо¿Ð§ÀÍ¡£¡£¡£¡£ËýµÄ±¨¸æÕ¹Ê¾ÁËÃÀ¸ß÷ÔÚҩЧÆÀ¼ÛÁìÓòµÄרҵÄÜÁ¦ºÍ¶ÔÐÐÒµÉú³¤µÄТ˳¡£¡£¡£¡£
ÔÚÃÀ¸ß÷Ӣ²Å¡°É½º£»£»£»á¡±Ô²×ÀÂÛ̳ÉÏ£¬£¬£¬£¬£¬ÃÀ¸ß÷Ê×ϯ¿ÆÑ§¹ÙÅíË«Çå½ÌÊÚºÍÊ×ϯÉÌÎñ¹Ù²Ì½ðÄȲ©Ê¿£¬£¬£¬£¬£¬ÓëÀ´×ÔѧÊõ½ç¡¢¹¤Òµ½çºÍͶ×ʽçµÄ¶¥¼âר¼Ò£¬£¬£¬£¬£¬ÅäºÏ̽ÌÖÁËCRO/CDMOÔÚ¼ÓËÙFICÒ©ÎïÉú³¤ÖеÄ×÷Ó㬣¬£¬£¬£¬ÒÔ¼°¸Éϸ°û¡¢ÍâÃÚÌåÑо¿¡¢ÐÂÒ»´úÉúÎïÖÎÁƵÈÁìÓòµÄ×îÐÂÏ£Íû¡£¡£¡£¡£×¨¼ÒÃÇ·ÖÏíÁËËûÃÇÔÚÐÂÒ»´úÉúÎïÖÎÁÆÁìÓòµÄÂÄÀú£¬£¬£¬£¬£¬ÌṩÁËÃû¹óµÄ¿´·¨ºÍÐÅÏ¢£¬£¬£¬£¬£¬ÓÐÖúÓÚÍÆ¶¯Ïà¹ØÁìÓòµÄÑо¿ºÍÓ¦Óᣡ£¡£¡£
CRO²»µ«ÌṩÑо¿¼¼ÊõÖ§³ÖºÍÏîÄ¿¹ÜÀíЧÀÍ£¬£¬£¬£¬£¬»¹Í¨¹ýÓë¿Í»§µÄϸÃÜÏàÖú£¬£¬£¬£¬£¬ÅäºÏÃæÁÙÑз¢Àú³ÌÖеÄÌôÕ½¡£¡£¡£¡£±¾´Î´ó»áΪÓë»áÕßÌṩÁËÒ»¸öÉîÈëÏàʶÐÐÒµ¶¯Ì¬¡¢½»Á÷Á¢ÒìÀíÄîºÍ½¨ÉèÏàÖú¹ØÏµµÄƽ̨¡£¡£¡£¡£ÃÀ¸ß÷ÓëÐÐҵͬÈÊЯÊÖÏàÖú£¬£¬£¬£¬£¬³ä·ÖÑéչһվʽÁÙ´²Ç°Ñз¢×ÛºÏÆ½Ì¨µÄЧÀÍÓÅÊÆ£¬£¬£¬£¬£¬ÅäºÏÍÆ¶¯ÐÐÒµ¼ÓËÙÉú³¤¡£¡£¡£¡£
Ïà¹ØÐÂÎÅʱ¼ä£º2021Äê03ÔÂ25-26ÈÕ
ËùÔÚ£ºÉϺ£ÍòºÀºçÇÅÂùÝ
ʱ¼ä£º2021Äê07ÔÂ01-02ÈÕ
ËùÔÚ£ºÎ人ÖÐÄÏ»¨Ô°Âùݣ¨ÄÏÔ·Â¥£©
ʱ¼ä£º2021Äê9ÔÂ25-27ÈÕ
ËùÔÚ£º´óÁ¬¹ú¼Ê¾Û»áÖÐÐÄ